The lung stents market is expected to reach USD 105.6 million by 2022 from an estimated USD 76.3 million in 2017, at a CAGR of 6.7% from 2017 to 2022. The rapidly increasing geriatric population, rising preference for minimally invasive procedures, high prevalence of tobacco smoking, and rising prevalence of lung cancer and other respiratory diseases are the major factors driving the growth of the significant growth drivers of lung stents market.
- Advertising -
Access Free Sample Report at www.reportsnreports.com/contacts/r…aspx?name=1243413 .
Lung stents market is segmented into tracheal stents and laryngeal stents. Tracheal stents segment is expected to register highest CAGR during forecast period.
High growth in this segment is attributed to rising incidence of lung cancer, increasing prevalence of chronic diseases such as COPD & asthma, rapid growth in geriatric population, and improving healthcare affordability in developed countries
Key Target Audience:
- Manufacturers and distributors of lung stents
- Healthcare institutions (hospitals and ambulatory surgery centres)
- Contract manufacturing organizations
- Research institutes
- Government associations
- Market research and consulting firms
- Venture capitalists and investors
Report analyzes various airway stent/lung stents market study papers.
- Advertising -
It aims at estimating market size and future growth potential of lung stents market for different segments such as type, product, procedure, material, end user, & region. Report also includes an in-depth competitive analysis of key players in this market along with their company profiles, product offerings, recent developments, & key market strategies.
More Information at www.reportsnreports.com/contacts/i…aspx?name=1243413 .
Rapidly increasing geriatric population, rising preference for minimally invasive procedures, high prevalence of tobacco smoking, & rising prevalence of lung cancer and other respiratory diseases are major factors driving growth of significant growth drivers of lung stents market. Availability of alternative treatments for target indications is limiting adoption of lung stents up to some stent.
2 Market Share Analysis
3 Competitive Scenario and Trends
5 Product Launch
7 Agreement and Expansion
8 Lung Stents Market: Product Portfolio Analysis
Some of the major market players in the lung stents market are Boston Scientific (US), C.R. Bard (US), Teleflex (US), Cook Group (US), Merit Medical Systems (US), Novatech (France), Fuji Systems (Japan), Taewoong Medical (South Korea), ENDO-FLEX (Germany), M.I.Tech (South Korea), Micro-Tech (Nanjing) (China), EFER ENDOSCOPY (France), Hood Laboratories (US), S&G BIOTECH (South Korea), Changzhou Health Microport Medical Device (China), and Kapitex Healthcare (UK).
Access report at www.reportsnreports.com/contacts/d…aspx?name=1243413 .
North America accounted for the largest share of the lung stents market in 2016, followed by Europe and Asia Pacific. The presence of a highly developed healthcare system, rising geriatric population, increasing incidence of lung cancer, quick adoption of new and innovative products, and a large number of lung stents manufacturing companies in this region are the major factors responsible for the large share of North America in the global lung stents market.
Key benefits of buying the Report:
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the thawing system market.
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the thawing system market